Poorer survival in stage IB lung cancer patients after pneumonectomy;La neumonectomía ofrece menor supervivencia a los pacientes con carcinoma de pulmón en estadio patológico IB

Archivos de Bronconeumologia

Volumn 51, Issue 5, 2015, Pages 223-226

  Rodríguez, María ^a   Gómez Hernández, María Teresa ^a   Novoa, Nuria M ^a   Aranda, José Luis ^a   Jiménez, Marcelo F ^a   Varela, Gonzalo ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Early stage; Lobectomy; Lung neoplasms; Pneumonectomy; Survival

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FORCED EXPIRATORY VOLUME; HUMAN; LOBECTOMY; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; ADJUVANT CHEMOTHERAPY; AGE; AGED; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; FOLLOW UP; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; ADULT; ALL CAUSE MORTALITY; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; INTERMETHOD COMPARISON; LUNG LOBECTOMY; NON SMALL CELL LUNG CANCER; SURGICAL TECHNIQUE;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PERIOPERATIVE CARE; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84928585612     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2015.03.006     Document Type: Article

References (14)

1. TNM Classification of Malignant Tumours 2009, Wiley-Blackwell, New York. 7th ed. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind (Eds.).
2. Rodríguez M., Gómez M.T., Jiménez M.F., Aranda J.L., Novoa N.M., Varela G. The risk of death due to cardiorespiratory causes increases with time after right pneumonectomy: A propensity score-matched analysis. Eur J Cardiothorac Surg 2013, 44:93-97.
3. Brunelli A., Charloux A., Bolliger C.T., Rocco G., Sculier J.P., Varela G., et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009, 34:17-41.
4. Brunelli A., Varela G., Salati M., Jimenez M.F., Pompili C., Novoa N., et al. Recalibration of the revised cardiac risk index in lung resection candidates. Ann Thorac Surg 2010, 90:199-203.
5. Lardinois D., de Leyn P., van Schil P., Porta R.R., Waller D., Passlick B., et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006, 30:787-792.
6. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
7. ESTS Database Committee. Database Annual Report. 2012 [consultado 12 Oct 2012]. Disponible en: . http://www.ests.org/documents/PDF/Database_ESTS_Report_2012.pdf.
8. Martin-Ucar A.E., Chaudhuri N., Edwards J.G., Waller D.A. Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery. Eur J Cardiothorac Surg 2002, 21:601-605.
9. Ohtaki Y., Hishida T., Yoshida J., Ishii G., Kawase A., Aokage K., et al. The clinical outcome of non-small cell lung cancer patients with adjacent lobe invasion: The optimal classification according to the status of the interlobar pleura at the invasion point. Eur J Cardiothorac Surg 2013, 43:302-309.
10. Okada M., Tsubota N., Yoshimura M., Miyamoto Y., Matsuoka H. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg 1999, 68:2049-2052.
11. Demir A., Gunluoglu M.Z., Sansar D., Melek H., Dincer S.I. Staging and resection of lung cancer with minimal invasion of the adjacent lobe. Eur J Cardiothorac Surg 2007, 32:855-858.
12. Joshi V., McShane J., Page R., Carr M., Mediratta N., Shackcloth M., et al. Clinical upstaging of non-small cell lung cancer that extends across the fissure: Implications for non-small cell lung cancer staging. Ann Thorac Surg 2011, 91:350-353.
13. Novoa N.M., Ballesteros E., Jiménez M.F., Aranda J.L., Varela G. Chest physiotherapy revisited: Evaluation of its influence on the overall cardio-respiratory morbidity after pulmonary resection. Eur J Cardiothorac Surg 2011, 40:130-134.
14. Varela G., Jiménez M.F., Hernández-Mezquita M. Seguimiento de los pacientes con cáncer de pulmón no microcítico. ¿Deben hacerlo los cirujanos?. Arch Bronconeumol 1998, 34:14-16.